How to Read a Peptide Certificate of Analysis (COA): Lots, Purity, and Limits
A certificate of analysis (COA) is often the first “quality document” a peptide buyer sees. Sellers post PDFs, screenshots, and batch summaries that highlight purity percentages in bold type. That visual confidence is understandable—especially when you are comparing vials and trying to reduce risk.
It is also incomplete. A COA is a test report for a specific sample, not a universal safety clearance for injectable use in humans. Learning to read one line by line helps you ask better questions, log better notes in PeptIQ, and avoid treating a marketing PDF like a prescription.
This guide is educational. It does not tell you what to inject, what dose to use, or which vendor to trust. Work with a licensed clinician and lawful channels for any medical product.
What a COA Is—and What It Is Not
A COA summarizes analytical results for a lot (batch) of material tested by a laboratory. Typical peptide COAs include identity confirmation, purity estimate, and sometimes residual solvents or water content. The document should name:
- The product (compound name and sometimes salt form)
- The lot or batch number tested
- The testing laboratory (name and sometimes accreditation)
- The test methods (for example HPLC, mass spectrometry)
- The results compared to specification limits
- The date of testing and approval signature or reviewer
What a standard research-vendor COA usually does not prove:
- Sterility suitable for injection
- Endotoxin limits for parenteral products
- Stability after shipping, freezing, or reconstitution
- That the vial in your hand came from the tested lot
- FDA approval or compounding pharmacy compliance
Think of a COA as one puzzle piece. PeptIQ helps you store the lot number next to your injection log so you can connect “what I used” with “what was tested”—if your supplier can demonstrate lot linkage at all.
Lot Numbers: The Chain of Custody Question
The most important field on many COAs is the lot number. Every vial you receive should be traceable to that lot—or you cannot honestly say the COA applies to your material.
Ask these chain-of-custody questions:
- Does the label on your vial match the lot on the COA?
- Was the COA issued before or after your ship date, and is it still the active lot?
- Does the seller publish one COA reused across many shipments?
- Can they explain splitting (one bulk test, many retail vials)?
If the answer to traceability is fuzzy, treat the COA as marketing. Your tracker should still record whatever lot string is on the label, plus source notes, so a clinician or pharmacist can interpret risk with real data.
For compounding workflows, pharmacists rely on supplier certificates tied to specific inbound lots used in preparation. That professional context is different from a screenshot on a product page. Our peptide regulation and sourcing overview explains why regulatory channel matters as much as a purity percentage.
Purity: HPLC Peaks and Specification Limits
Purity on peptide COAs usually means the area percent of the main peak in high-performance liquid chromatography (HPLC) or a related chromatographic method. You will see language like “≥ 98.0%” or “purity: 99.1%.”
How to read the purity line
- Main peak: the intended peptide sequence (hopefully).
- Impurity peaks: related sequences, deletion peptides, or isomers.
- Specification: the pass/fail window the supplier set—often stricter on paper than what regulators require for research grade.
High purity reduces one class of risk (wrong or mixed sequence material) but does not eliminate:
- Aggregation after storage
- Degradation products that appear over time
- Contamination from non-peptide sources not on the COA panel
When people compare lyophilized versus reconstituted states, remember that purity was measured on tested material at test time, not necessarily on your reconstituted solution weeks later.
Identity testing: purity is not identity
A COA should also show identity confirmation—often mass spectrometry (MS), amino acid analysis, or peptide mapping. Purity without identity is weaker evidence.
Look for:
- Molecular weight or m/z consistent with the named sequence
- Method reference (for example “LC-MS per internal SOP”)
- Clear analyte name matching the product you think you bought
If identity is missing, ask why before trusting the purity headline.
Other Common COA Lines (Water, Solvents, Appearance)
Research COAs may report:
- Water content (Karl Fischer) — relevant to how much peptide is “active” by weight
- Residual solvents — manufacturing carryover
- Appearance — cake color, clarity after reconstitution (if tested)
- Bacterial endotoxins — sometimes present on pharmacy-grade certificates, rare on hobby research COAs
None of these replace sterility testing for injectable preparations. U.S. Pharmacopeia (USP) compounding chapters emphasize appropriate testing and beyond-use dating for sterile preparations prepared under applicable standards—another reason channel and supervision matter.
